| Greenbrier Audiology, Inc. | |
|
2216 S Kanawha St, Beckley, WV 25801-6720 | |
| (304) 255-6310 | |
| (304) 255-6320 |
| Full Name | Greenbrier Audiology, Inc. |
|---|---|
| Type | Facility |
| Speciality | Audiologist |
| Location | 2216 S Kanawha St, Beckley, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710321377 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | A-0051 (West Virginia) | Primary |
| Provider Name | Amanda S Means |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1619189032 PECOS PAC ID: 2860570470 Enrollment ID: I20080423000195 |
News Archive
Parkinson's disease, a disorder which affects movement and cognition, affects over a million Americans, including actor Michael J. Fox, who first brought it to the attention of many TV-watching Americans. It's characterized by a gradual loss of neurons that produce dopamine. Mutations in the gene known as DJ-1 lead to accelerated loss of dopaminergic neurons and result in the onset of Parkinson's symptoms at a young age.
Nerve damage from neurodegenerative disease and spinal cord injury has largely been considered irreversible, but Dartmouth researchers report progress in the effort to synthesize rare natural products that promote regeneration and growth of injured nerve cells.
As the annual open enrollment period approaches Medicare Advantage plan enrollment continues to inch upwards, with nearly 11.8 million people enrolled as of August 2010, almost 25% of all Medicare beneficiaries. Despite conservative growth strategies, stricter marketing regulations and legislation which reined in popular Private-Fee-For-Service plans, Medicare Advantage companies are still experiencing single digit growth rates, according to a new report by Mark Farrah Associates, a leading provider of market data and intelligence solutions.
A brand-new technique of gene therapy was reported on December 16, 2019, in the journal Nature Biomedical Engineering. The scientists made use of the potential of human cells to produce biological nanoparticles chockful of edited genes, so that they could insert beneficial genes into people suffering from various disease processes.
Midatech Biogune S. L., the nanoparticle manufacturing subsidiary of the Midatech Group, a global leader and centre of excellence for the design, development, synthesis and manufacture of nanomedicines, is pleased to announce that it has been granted an Investigational Medicinal Products (IMP) License from the Spanish Medicines Agency for the cGMP manufacture of clinical grade nanoparticles at its state-of-the art facility in Bilbao, Spain.
› Verified 5 days ago
| Provider Name | Laura Stout |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1699784264 PECOS PAC ID: 9638307283 Enrollment ID: I20140106001413 |
News Archive
Parkinson's disease, a disorder which affects movement and cognition, affects over a million Americans, including actor Michael J. Fox, who first brought it to the attention of many TV-watching Americans. It's characterized by a gradual loss of neurons that produce dopamine. Mutations in the gene known as DJ-1 lead to accelerated loss of dopaminergic neurons and result in the onset of Parkinson's symptoms at a young age.
Nerve damage from neurodegenerative disease and spinal cord injury has largely been considered irreversible, but Dartmouth researchers report progress in the effort to synthesize rare natural products that promote regeneration and growth of injured nerve cells.
As the annual open enrollment period approaches Medicare Advantage plan enrollment continues to inch upwards, with nearly 11.8 million people enrolled as of August 2010, almost 25% of all Medicare beneficiaries. Despite conservative growth strategies, stricter marketing regulations and legislation which reined in popular Private-Fee-For-Service plans, Medicare Advantage companies are still experiencing single digit growth rates, according to a new report by Mark Farrah Associates, a leading provider of market data and intelligence solutions.
A brand-new technique of gene therapy was reported on December 16, 2019, in the journal Nature Biomedical Engineering. The scientists made use of the potential of human cells to produce biological nanoparticles chockful of edited genes, so that they could insert beneficial genes into people suffering from various disease processes.
Midatech Biogune S. L., the nanoparticle manufacturing subsidiary of the Midatech Group, a global leader and centre of excellence for the design, development, synthesis and manufacture of nanomedicines, is pleased to announce that it has been granted an Investigational Medicinal Products (IMP) License from the Spanish Medicines Agency for the cGMP manufacture of clinical grade nanoparticles at its state-of-the art facility in Bilbao, Spain.
› Verified 5 days ago
| Provider Name | Kristin Shockey |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1316385503 PECOS PAC ID: 7113141037 Enrollment ID: I20140617000201 |
News Archive
Parkinson's disease, a disorder which affects movement and cognition, affects over a million Americans, including actor Michael J. Fox, who first brought it to the attention of many TV-watching Americans. It's characterized by a gradual loss of neurons that produce dopamine. Mutations in the gene known as DJ-1 lead to accelerated loss of dopaminergic neurons and result in the onset of Parkinson's symptoms at a young age.
Nerve damage from neurodegenerative disease and spinal cord injury has largely been considered irreversible, but Dartmouth researchers report progress in the effort to synthesize rare natural products that promote regeneration and growth of injured nerve cells.
As the annual open enrollment period approaches Medicare Advantage plan enrollment continues to inch upwards, with nearly 11.8 million people enrolled as of August 2010, almost 25% of all Medicare beneficiaries. Despite conservative growth strategies, stricter marketing regulations and legislation which reined in popular Private-Fee-For-Service plans, Medicare Advantage companies are still experiencing single digit growth rates, according to a new report by Mark Farrah Associates, a leading provider of market data and intelligence solutions.
A brand-new technique of gene therapy was reported on December 16, 2019, in the journal Nature Biomedical Engineering. The scientists made use of the potential of human cells to produce biological nanoparticles chockful of edited genes, so that they could insert beneficial genes into people suffering from various disease processes.
Midatech Biogune S. L., the nanoparticle manufacturing subsidiary of the Midatech Group, a global leader and centre of excellence for the design, development, synthesis and manufacture of nanomedicines, is pleased to announce that it has been granted an Investigational Medicinal Products (IMP) License from the Spanish Medicines Agency for the cGMP manufacture of clinical grade nanoparticles at its state-of-the art facility in Bilbao, Spain.
› Verified 5 days ago
| Provider Name | Lori Ann Ziolkowski |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1881095230 PECOS PAC ID: 3870815608 Enrollment ID: I20141206000257 |
News Archive
Parkinson's disease, a disorder which affects movement and cognition, affects over a million Americans, including actor Michael J. Fox, who first brought it to the attention of many TV-watching Americans. It's characterized by a gradual loss of neurons that produce dopamine. Mutations in the gene known as DJ-1 lead to accelerated loss of dopaminergic neurons and result in the onset of Parkinson's symptoms at a young age.
Nerve damage from neurodegenerative disease and spinal cord injury has largely been considered irreversible, but Dartmouth researchers report progress in the effort to synthesize rare natural products that promote regeneration and growth of injured nerve cells.
As the annual open enrollment period approaches Medicare Advantage plan enrollment continues to inch upwards, with nearly 11.8 million people enrolled as of August 2010, almost 25% of all Medicare beneficiaries. Despite conservative growth strategies, stricter marketing regulations and legislation which reined in popular Private-Fee-For-Service plans, Medicare Advantage companies are still experiencing single digit growth rates, according to a new report by Mark Farrah Associates, a leading provider of market data and intelligence solutions.
A brand-new technique of gene therapy was reported on December 16, 2019, in the journal Nature Biomedical Engineering. The scientists made use of the potential of human cells to produce biological nanoparticles chockful of edited genes, so that they could insert beneficial genes into people suffering from various disease processes.
Midatech Biogune S. L., the nanoparticle manufacturing subsidiary of the Midatech Group, a global leader and centre of excellence for the design, development, synthesis and manufacture of nanomedicines, is pleased to announce that it has been granted an Investigational Medicinal Products (IMP) License from the Spanish Medicines Agency for the cGMP manufacture of clinical grade nanoparticles at its state-of-the art facility in Bilbao, Spain.
› Verified 5 days ago
| Provider Name | Emily Stout |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1285276501 PECOS PAC ID: 1759704679 Enrollment ID: I20200710002767 |
News Archive
Parkinson's disease, a disorder which affects movement and cognition, affects over a million Americans, including actor Michael J. Fox, who first brought it to the attention of many TV-watching Americans. It's characterized by a gradual loss of neurons that produce dopamine. Mutations in the gene known as DJ-1 lead to accelerated loss of dopaminergic neurons and result in the onset of Parkinson's symptoms at a young age.
Nerve damage from neurodegenerative disease and spinal cord injury has largely been considered irreversible, but Dartmouth researchers report progress in the effort to synthesize rare natural products that promote regeneration and growth of injured nerve cells.
As the annual open enrollment period approaches Medicare Advantage plan enrollment continues to inch upwards, with nearly 11.8 million people enrolled as of August 2010, almost 25% of all Medicare beneficiaries. Despite conservative growth strategies, stricter marketing regulations and legislation which reined in popular Private-Fee-For-Service plans, Medicare Advantage companies are still experiencing single digit growth rates, according to a new report by Mark Farrah Associates, a leading provider of market data and intelligence solutions.
A brand-new technique of gene therapy was reported on December 16, 2019, in the journal Nature Biomedical Engineering. The scientists made use of the potential of human cells to produce biological nanoparticles chockful of edited genes, so that they could insert beneficial genes into people suffering from various disease processes.
Midatech Biogune S. L., the nanoparticle manufacturing subsidiary of the Midatech Group, a global leader and centre of excellence for the design, development, synthesis and manufacture of nanomedicines, is pleased to announce that it has been granted an Investigational Medicinal Products (IMP) License from the Spanish Medicines Agency for the cGMP manufacture of clinical grade nanoparticles at its state-of-the art facility in Bilbao, Spain.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Greenbrier Audiology, Inc. 2216 S Kanawha St, Beckley, WV 25801-6720 Ph: (304) 255-6310 | Greenbrier Audiology, Inc. 2216 S Kanawha St, Beckley, WV 25801-6720 Ph: (304) 255-6310 |
News Archive
Parkinson's disease, a disorder which affects movement and cognition, affects over a million Americans, including actor Michael J. Fox, who first brought it to the attention of many TV-watching Americans. It's characterized by a gradual loss of neurons that produce dopamine. Mutations in the gene known as DJ-1 lead to accelerated loss of dopaminergic neurons and result in the onset of Parkinson's symptoms at a young age.
Nerve damage from neurodegenerative disease and spinal cord injury has largely been considered irreversible, but Dartmouth researchers report progress in the effort to synthesize rare natural products that promote regeneration and growth of injured nerve cells.
As the annual open enrollment period approaches Medicare Advantage plan enrollment continues to inch upwards, with nearly 11.8 million people enrolled as of August 2010, almost 25% of all Medicare beneficiaries. Despite conservative growth strategies, stricter marketing regulations and legislation which reined in popular Private-Fee-For-Service plans, Medicare Advantage companies are still experiencing single digit growth rates, according to a new report by Mark Farrah Associates, a leading provider of market data and intelligence solutions.
A brand-new technique of gene therapy was reported on December 16, 2019, in the journal Nature Biomedical Engineering. The scientists made use of the potential of human cells to produce biological nanoparticles chockful of edited genes, so that they could insert beneficial genes into people suffering from various disease processes.
Midatech Biogune S. L., the nanoparticle manufacturing subsidiary of the Midatech Group, a global leader and centre of excellence for the design, development, synthesis and manufacture of nanomedicines, is pleased to announce that it has been granted an Investigational Medicinal Products (IMP) License from the Spanish Medicines Agency for the cGMP manufacture of clinical grade nanoparticles at its state-of-the art facility in Bilbao, Spain.
› Verified 5 days ago
Ms. Diana Lynn Janney, MS,CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 200 Veterans Ave, Beckley, WV 25801 Phone: 304-255-2121 Fax: 304-256-5142 | |
Emily Miller, AUD Audiologist Medicare: May Accept Medicare Assignments Practice Location: 2216 S Kanawha St, Beckley, WV 25801 Phone: 304-880-3746 | |
Serena Hart, M.S., C.C.C.-A Audiologist Medicare: Medicare Enrolled Practice Location: 2216 S Kanawha St, Beckley, WV 25801 Phone: 304-255-6310 | |
Ms. Tina Louise Blankenship I, M.S.CCC/A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 200 Veterans Ave, Beckley, WV 25801 Phone: 304-255-2121 | |
Mr. Phillip K Bond, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 200 Veterans Ave, Beckley, WV 25801 Phone: 304-255-2121 | |
Pamela Klug Whitmore, MA,CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 218 Ragland Rd, Beckley, WV 25801 Phone: 304-252-0790 Fax: 304-253-9470 |